Source: Applied Immunohistochemistry & Molecular Morphology. Unidade: FM
Subjects: NEOPLASIAS MAMÁRIAS (INCIDÊNCIA), TESTES SOROLÓGICOS, PROGNÓSTICO, IMUNOHISTOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WLUDARSKI, Sheila Cristina Lordelo et al. HER2 Testing in Breast Carcinoma: Very Low Concordance Rate Between Reference and Local Laboratories in Brazil. Applied Immunohistochemistry & Molecular Morphology, v. 19, n. 2, p. 112-118, 2011Tradução . . Disponível em: https://doi.org/10.1097/PAI.0b013e3181f0b044. Acesso em: 21 maio 2024.APA
Wludarski, S. C. L., Lopes, L. F., Berto e Silva, T. R., Carvalho, F. M., Weiss, L. M., & Bacchi, C. E. (2011). HER2 Testing in Breast Carcinoma: Very Low Concordance Rate Between Reference and Local Laboratories in Brazil. Applied Immunohistochemistry & Molecular Morphology, 19( 2), 112-118. doi:10.1097/PAI.0b013e3181f0b044NLM
Wludarski SCL, Lopes LF, Berto e Silva TR, Carvalho FM, Weiss LM, Bacchi CE. HER2 Testing in Breast Carcinoma: Very Low Concordance Rate Between Reference and Local Laboratories in Brazil [Internet]. Applied Immunohistochemistry & Molecular Morphology. 2011 ; 19( 2): 112-118.[citado 2024 maio 21 ] Available from: https://doi.org/10.1097/PAI.0b013e3181f0b044Vancouver
Wludarski SCL, Lopes LF, Berto e Silva TR, Carvalho FM, Weiss LM, Bacchi CE. HER2 Testing in Breast Carcinoma: Very Low Concordance Rate Between Reference and Local Laboratories in Brazil [Internet]. Applied Immunohistochemistry & Molecular Morphology. 2011 ; 19( 2): 112-118.[citado 2024 maio 21 ] Available from: https://doi.org/10.1097/PAI.0b013e3181f0b044